We'll see you soon 🫡 in Paris for the 9th edition of @immunorad conference ☢️/🧫on September 17-19, 2025. Our Abstract 📜 was sent and sellected to Poster and We have more science 🧬 to share with you. 🧐🤗
Ruiz-Fernández de Córdoba, B., Valencia, K., Welch, C. et al. Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer. Sig Transduct Target Ther 10, 185 (2025). https://t.co/6ONMFlmogs
The Adhesion and Metastasis Lab in CIMA is opening a three-year PhD position. We are looking for highly motivated candidates to join projects to characterize novel candidates involved in Loco-regional failure and unveil novel therapeutic approaches in breast cancer.
Review @CCR_AACR from Borja Ruiz-Fernández de Córdoba, Rafael Martínez-Monge, Fernando Lecanda
@CIMA_unav @CIBERONC
ENPP1 Immunobiology as a Therapeutic Target https://t.co/5j85Os7JKr
Investigadores del Cima Universidad de Navarra identifican un gen clave en el desarrollo y tratamiento del cáncer de páncreas https://t.co/bNht8p8ZvG vía @noticiasnavarra
La Clínica se viste🎀con motivo del #DiaMundialCancerMama
Es nuestro homenaje a quien se enfrenta al #cáncerdemama y a quien como nosotros desde hace 60 años, trabaja a todos los niveles -asistencial, investigador, compartiendo conocimiento- para mejorar su supervivencia. CONTIGO